168 related articles for article (PubMed ID: 12173577)
1. Long-term efficacy of interferon-alpha in chronic inflammatory demyelinating polyneuropathy.
Pavesi G; Cattaneo L; Marbini A; Gemignani F; Mancia D
J Neurol; 2002 Jun; 249(6):777-9. PubMed ID: 12173577
[No Abstract] [Full Text] [Related]
2. Intravenous immunoglobulin as first treatment in diabetics with concomitant distal symmetric axonal polyneuropathy and CIDP.
Cocito D; Ciaramitaro P; Isoardo G; Barbero P; Migliaretti G; Pipieri A; Proto G; Quadri R; Bergamasco B; Durelli L
J Neurol; 2002 Jun; 249(6):719-22. PubMed ID: 12111305
[TBL] [Abstract][Full Text] [Related]
3. Clinical and electrophysiologic correlates of IVIg responsiveness in CIDP.
Iijima M; Yamamoto M; Hirayama M; Tanaka F; Katsuno M; Mori K; Koike H; Hattori N; Arimura K; Nakagawa M; Yoshikawa H; Hayasaka K; Onodera O; Baba M; Yasuda H; Saito T; Nakazato M; Nakashima K; Kira J; Kaji R; Oka N; Sobue G
Neurology; 2005 Apr; 64(8):1471-5. PubMed ID: 15851750
[TBL] [Abstract][Full Text] [Related]
4. Chronic inflammatory demyelinating polyradiculoneuropathy in diabetic patients.
Haq RU; Pendlebury WW; Fries TJ; Tandan R
Muscle Nerve; 2003 Apr; 27(4):465-70. PubMed ID: 12661048
[TBL] [Abstract][Full Text] [Related]
5. Chronic inflammatory demyelinating polyneuropathy in a diabetic patient: deterioration after intravenous immunoglobulins treatment and favorable response to steroid treatment.
Pedersen K; Pandolfo M; Mavroudakis N
Acta Neurol Belg; 2007 Mar; 107(1):14-7. PubMed ID: 17569228
[TBL] [Abstract][Full Text] [Related]
6. Chronic inflammatory demyelinating polyneuropathy associated with tumor necrosis factor-alpha antagonists.
Alshekhlee A; Basiri K; Miles JD; Ahmad SA; Katirji B
Muscle Nerve; 2010 May; 41(5):723-7. PubMed ID: 20405504
[TBL] [Abstract][Full Text] [Related]
7. Intravenous immunoglobulin (IVIG) in the treatment of chronic demyelinating polyradiculoneuropathy.
Van den Bergh PY
Acta Neurol Belg; 2001 Sep; 101(3):147-51. PubMed ID: 11817262
[No Abstract] [Full Text] [Related]
8. Neuropathy resembling CIDP in patients receiving tumor necrosis factor-alpha blockers.
Richez C; Blanco P; Lagueny A; Schaeverbeke T; Dehais J
Neurology; 2005 Apr; 64(8):1468-70. PubMed ID: 15851749
[TBL] [Abstract][Full Text] [Related]
9. Chronic inflammatory demyelinating polyneuropathy following treatment with peglated interferon α-2a for chronic hepatitis C virus infection.
Ying C; Xue-Mei H; Yao G; Song-Yan L
Neurol India; 2011; 59(1):141-2. PubMed ID: 21339691
[No Abstract] [Full Text] [Related]
10. Treatment-responsive pudendal dysfunction in chronic inflammatory demyelinating polyneuropathy.
Bussemaker L; Schelhaas HJ; Overeem S; Hopman WP; Zwarts MJ
Neurology; 2007 Mar; 68(12):957-8. PubMed ID: 17372137
[No Abstract] [Full Text] [Related]
11. Distal acquired demyelinating symmetric polyneuropathy progressing to classic chronic inflammatory demyelinating polyneuropathy and response to fludarabine and cyclophosphamide.
Leitch MM; Sherman WH; Brannagan TH
Muscle Nerve; 2013 Feb; 47(2):292-6. PubMed ID: 23168526
[TBL] [Abstract][Full Text] [Related]
12. Modulatory effects on axonal function after intravenous immunoglobulin therapy in chronic inflammatory demyelinating polyneuropathy.
Lin CS; Krishnan AV; Park SB; Kiernan MC
Arch Neurol; 2011 Jul; 68(7):862-9. PubMed ID: 21747028
[TBL] [Abstract][Full Text] [Related]
13. Chronic acquired demyelinating polyneuropathies.
Saperstein DS
Semin Neurol; 2008 Apr; 28(2):168-84. PubMed ID: 18351519
[TBL] [Abstract][Full Text] [Related]
14. Long-standing idiopathic hypoparathyroidism masking coexistent chronic inflammatory demyelinating polyneuropathy.
França MC; de Castro R; de Oliveira MF; Garibaldi SG; Nucci A; de Souza Queiroz L; Kraemer MH
J Peripher Nerv Syst; 2004 Dec; 9(4):196-7. PubMed ID: 15574130
[No Abstract] [Full Text] [Related]
15. Immunosuppressive treatment in refractory chronic inflammatory demyelinating polyradiculoneuropathy. A nationwide retrospective analysis.
Cocito D; Grimaldi S; Paolasso I; Falcone Y; Antonini G; Benedetti L; Briani C; Fazio R; Jann S; Matà S; Sabatelli M; Nobile-Orazio E;
Eur J Neurol; 2011 Dec; 18(12):1417-21. PubMed ID: 21819489
[TBL] [Abstract][Full Text] [Related]
16. Nerve Ultrasound, Electrophysiological, and Clinical Changes in Treatment-Naive Chronic Inflammatory Demyelinating Polyneuropathy: A Case Report.
Sato T; Terasawa Y; Higa H; Matsuno H; Arai A; Omoto S; Mitsumura H; Toyoda C; Koike H; Iguchi Y
J Clin Neurophysiol; 2019 Jan; 36(1):82-84. PubMed ID: 30260816
[TBL] [Abstract][Full Text] [Related]
17. Long-term effects of intravenous immunoglobulin in CIDP.
Vucic S; Black K; Baldassari LE; Tick Chong PS; Dawson KT; Cros D
Clin Neurophysiol; 2007 Sep; 118(9):1980-4. PubMed ID: 17604689
[TBL] [Abstract][Full Text] [Related]
18. Intractable chronic inflammatory demyelinating polyneuropathy treated successfully with ciclosporin.
Odaka M; Tatsumoto M; Susuki K; Hirata K; Yuki N
J Neurol Neurosurg Psychiatry; 2005 Aug; 76(8):1115-20. PubMed ID: 16024890
[TBL] [Abstract][Full Text] [Related]
19. Response to treatment in patients with Lewis-Sumner syndrome.
Attarian S; Verschueren A; Franques J; Salort-Campana E; Jouve E; Pouget J
Muscle Nerve; 2011 Aug; 44(2):179-84. PubMed ID: 21755505
[TBL] [Abstract][Full Text] [Related]
20. Chronic inflammatory axonal polyneuropathy.
Oh SJ; Lu L; Alsharabati M; Morgan MB; King P
J Neurol Neurosurg Psychiatry; 2020 Nov; 91(11):1175-1180. PubMed ID: 32917820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
